Sepsis is a life-threatening condition with severe long-term health consequences and a high mortality rate. Early diagnosis is crucial to address these challenges. However, typical diagnostic procedures for suspected sepsis, …
Preliminary Clinical Method Comparison of a Point-of-Care Platform for anti-Factor Xa in Pediatric Patients on Heparin Therapy
Frequent monitoring for anti-Factor Xa activity (aFXa) and/or activated partial thromboplastin time (aPTT) is required for children receiving heparin therapy to achieve hemostatic balance. However, current heparin tests demand large …
Unique Challenges to Heparin Monitoring in Neonatal and Pediatric Populations
A Need for Small Volume and Rapid Anticoagulation Assays at the Point of Care Each year, around 40,000 newborns are diagnosed with congenital heart defects1 and some of them may …
Digital Microfluidics Proves Its Performance
Following Successful Evaluation, GOSH Team Shares Results in Award-Winning Presentation A recent evaluation of the SEEKER® digital microfluidics (DMF) platform in the United Kingdom demonstrated its fit-for-purpose as a routine …
Ask the Experts: Late Onset Pompe Disease
Anyone who observes Dr. Kishnani with her patients and their families will understand her passion for and dedication to treating Pompe Disease. An award-winning and globally acknowledged expert in the …
International Women in Science Day
We’re celebrating International Women in Science Day by spotlighting our CLIA laboratory team! Staffed entirely by women, these scientists are driven by our mission and passionate about finding answers that …
Medical Horizons and Baebies Expand Partnership
December 14, 2022 – Florence, Italy Baebies today announced it is expanding its partnership with medical device supplier Medical Horizons S.r.L to help bring newborn screening solutions to a greater …
Baebies Receives FDA 510(k) Clearance for G6PD Test on FINDER Platform
DURHAM, N.C. – (November 9, 2022) – Baebies has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its rapid, point-of-care test for glucose-6-phosphate dehydrogenase (G6PD) deficiency. The test …
Rapid, Near-Patient Monitoring of Heparin in Children
Multifunctional Platform for Viscoelastic aPTT and Fluorometric aFXa Whole Blood Testing in Near-Patient Settings for Pediatric Patients on Heparin Therapy Heparin monitoring tests for anti-Factor Xa activity (aFXa) and activated …
Near-Patient Digital Microfluidics G6PD Assay
Preliminary Investigation into the Prevalence of G6PD Deficiency in a Pediatric African American Population using a Near-Patient Diagnostic Platform In this study, a near-patient digital microfluidics (DMF) glucose-6-phosphate dehydrogenase (G6PD) …